KR20140144255A - 생체관련 조성물 - Google Patents

생체관련 조성물 Download PDF

Info

Publication number
KR20140144255A
KR20140144255A KR1020147030491A KR20147030491A KR20140144255A KR 20140144255 A KR20140144255 A KR 20140144255A KR 1020147030491 A KR1020147030491 A KR 1020147030491A KR 20147030491 A KR20147030491 A KR 20147030491A KR 20140144255 A KR20140144255 A KR 20140144255A
Authority
KR
South Korea
Prior art keywords
bio
sodium
medium
composition
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147030491A
Other languages
English (en)
Korean (ko)
Inventor
메튜 루이스 스티븐 레이
스티브 레이
제니퍼 드레스맨
바스티안 클로에퍼
마르셀 아른드트
알렉산더 후크스
Original Assignee
파레스 파머수티컬 리서치 엔.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파레스 파머수티컬 리서치 엔.브이. filed Critical 파레스 파머수티컬 리서치 엔.브이.
Publication of KR20140144255A publication Critical patent/KR20140144255A/ko
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Computational Mathematics (AREA)
  • Educational Administration (AREA)
  • Mathematical Analysis (AREA)
  • Business, Economics & Management (AREA)
  • Algebra (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Educational Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fodder In General (AREA)
KR1020147030491A 2012-03-30 2013-04-02 생체관련 조성물 Ceased KR20140144255A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12162548.7A EP2645099A1 (en) 2012-03-30 2012-03-30 Biorelevant compositions
EP12162548.7 2012-03-30
PCT/EP2013/056945 WO2013144374A1 (en) 2012-03-30 2013-04-02 Biorelevant compositions

Publications (1)

Publication Number Publication Date
KR20140144255A true KR20140144255A (ko) 2014-12-18

Family

ID=48143258

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147030491A Ceased KR20140144255A (ko) 2012-03-30 2013-04-02 생체관련 조성물

Country Status (11)

Country Link
US (1) US20150064794A1 (https=)
EP (2) EP2645099A1 (https=)
JP (1) JP6348480B2 (https=)
KR (1) KR20140144255A (https=)
CN (1) CN104582689A (https=)
BR (1) BR112014024256A8 (https=)
CA (1) CA2867638A1 (https=)
IN (1) IN2014DN07927A (https=)
MX (1) MX357927B (https=)
NZ (1) NZ700064A (https=)
WO (1) WO2013144374A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034606B1 (ko) * 2011-08-23 2019-10-22 알레간 세일즈, 엘엘씨 데옥시콜린산 및 그의 염들의 제형물들
WO2019199238A1 (en) * 2018-04-09 2019-10-17 Vet Products Research And Innovation Center Company Limited Inorganic mineral entrapped in nanoparticle production method thereof
GB201809627D0 (en) * 2018-06-12 2018-07-25 Biorelevant Com Ltd Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling
GB201904757D0 (en) * 2019-04-04 2019-05-22 Biorelevant Com Ltd Biorelevant composition
CN114080539A (zh) * 2019-06-28 2022-02-22 詹森药业有限公司 生物相关溶出介质
WO2021165386A1 (de) 2020-02-19 2021-08-26 Bayer Aktiengesellschaft Vorhersage von formulierungseigenschaften
GB202112975D0 (en) 2021-09-10 2021-10-27 Biorelevant Com Ltd Biorelevant dissolution compositions with reproducible spectral profiles
GB202405714D0 (en) * 2024-04-23 2024-06-05 Biorelevant Com Ltd Biorelevant compositions and media for in vitro testing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
GB8909022D0 (en) * 1989-04-20 1989-06-07 Cortecs Ltd Pharmaceutical compositions
US6040188A (en) * 1997-11-18 2000-03-21 The Regents Of The University Of California In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
WO2003042392A1 (en) * 2001-11-15 2003-05-22 Phares Pharmaceutical Research N.V. Standardised phospholipid mixtures
CA2560900A1 (en) * 2004-03-26 2005-10-06 Cell Therapeutics Europe S.R.L. Nanoparticle formulations of platinum compounds
GB0522942D0 (en) * 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
WO2007085970A2 (en) * 2006-01-27 2007-08-02 Danisco A/S Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
WO2008040799A2 (en) 2006-10-06 2008-04-10 Boehringer Ingelheim International Gmbh Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release

Also Published As

Publication number Publication date
NZ700064A (en) 2016-08-26
BR112014024256A2 (https=) 2017-06-20
IN2014DN07927A (https=) 2015-05-01
BR112014024256A8 (pt) 2018-02-06
EP2645099A1 (en) 2013-10-02
CA2867638A1 (en) 2013-10-03
US20150064794A1 (en) 2015-03-05
MX2014011789A (es) 2015-06-03
JP2015524913A (ja) 2015-08-27
MX357927B (es) 2018-07-27
WO2013144374A1 (en) 2013-10-03
CN104582689A (zh) 2015-04-29
JP6348480B2 (ja) 2018-06-27
EP2830592A1 (en) 2015-02-04

Similar Documents

Publication Publication Date Title
KR20140144255A (ko) 생체관련 조성물
US8889189B2 (en) Dissolution composition for examining drug solubility
Khadra et al. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs
Rabel et al. The differences of the impact of a lipid and protein corona on the colloidal stability, toxicity, and degradation behavior of iron oxide nanoparticles
Yeap et al. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs
Walsh et al. Comparing dog and human intestinal fluids: implications on solubility and biopharmaceutical risk assessment
Kihara et al. The “gut” corona at the surface of nanoparticles is dependent on exposure to bile salts and phospholipids
WO2019143637A1 (en) Methods and compositions for quantifying hemoglobin
Gadd et al. High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
JP7580392B2 (ja) 生体関連組成物
EP3990914B1 (en) Biorelevant dissolution media
RU2848693C1 (ru) Порошок для приготовления биорелевантных сред, имитирующих состав отделов желудочно-кишечного тракта человека
WO2014069651A1 (ja) Ｅｌ活性が関連する疾患の治療または予防効果を有する医薬の薬効評価方法及びｅｌ活性阻害物質のスクリーニング方法
Zhou Novel experimental techniques for biopharmaceutical analysis
Rao et al. Comparative dissolution studies of marketed tablets of telmisartan in biorelevant media

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141029

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20171215

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180316

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191024

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20200106

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20191024

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I